Literature DB >> 19180134

Relationship between Escherichia coli O157:H7 and diabetes mellitus.

Rita S Suri1, Jeffrey L Mahon, William F Clark, Louise M Moist, Marina Salvadori, Amit X Garg.   

Abstract

Ingestion of Escherichia coli O157:H7 can cause a spectrum of acute illness, ranging from overt hemolytic-uremic syndrome (HUS), to gastroenteritis with bloody diarrhea, to no symptoms. This organism has been responsible for dozens of outbreaks of gastroenteritis and HUS in industrialized nations, and thus is a major public health concern. Although the acute effects of E. coli O157:H7 ingestion are well understood, the long-term complications are less well known. Here, we review the biological and empirical evidence supporting a link between E. coli O157:H7 and long-term diabetes mellitus. Survivors with diarrhea-associated HUS have a significantly increased incidence of diabetes due to complete insulin deficiency, which may recur several years after the initial infection. However, less severe forms of infection, such as E. coli O157:H7 gastroenteritis without overt HUS, do not appear to result in an increased risk of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19180134     DOI: 10.1038/ki.2008.619

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

Review 2.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

Review 3.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

4.  Outbreak of Escherichia coli and diabetes mellitus.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Endocrinol Metab       Date:  2011-07

5.  Cytosolic and Calcium-Independent Phospholipases A2 Activation and Prostaglandins E2 Are Associated with Escherichia coli-Induced Reduction of Insulin Secretion in INS-1E Cells.

Authors:  Nunzia Caporarello; Mario Salmeri; Marina Scalia; Carla Motta; Cristina Parrino; Lucia Frittitta; Melania Olivieri; Martina Cristaldi; Roberto Avola; Vincenzo Bramanti; Maria Antonietta Toscano; Carmelina Daniela Anfuso; Gabriella Lupo
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

6.  Houttuynia cordata Facilitates Metformin on Ameliorating Insulin Resistance Associated with Gut Microbiota Alteration in OLETF Rats.

Authors:  Jing-Hua Wang; Shambhunath Bose; Soo-Kyoung Lim; AbuZar Ansari; Young-Won Chin; Han Seok Choi; Hojun Kim
Journal:  Genes (Basel)       Date:  2017-09-22       Impact factor: 4.096

Review 7.  Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia.

Authors:  Jesús Chávez-Reyes; Carlos E Escárcega-González; Erika Chavira-Suárez; Angel León-Buitimea; Priscila Vázquez-León; José R Morones-Ramírez; Carlos M Villalón; Andrés Quintanar-Stephano; Bruno A Marichal-Cancino
Journal:  Front Public Health       Date:  2021-02-16

Review 8.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.